STOCK TITAN
  1. Home
  2. Sec-filings
  3. RAPP
  4. [EFFECT] Rapport Therapeutics, Inc. SEC Filing

[EFFECT] Rapport Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
-
-
-
-
-
Positive
  • None.
Negative
  • None.
-
-
-
-
-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 9, 2025 4:01 P.M.
Form: S-3
CIK: 0002012593
Company Name: Rapport Therapeutics, Inc.
File Number: 333-288444

Source: View Original Filing on SEC EDGAR

Stock RAPP logo
Rapport Therapeutics Inc

NASDAQ:RAPP

RAPP Rankings

#4814 Ranked by Market Cap
N/A Ranked by Dividends

RAPP Latest News

Jun 2, 2025
Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates
May 27, 2025
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference
May 21, 2025
Rapport Therapeutics to Host 2025 Investor and Analyst Day
May 8, 2025
Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update
Apr 22, 2025
Rapport Therapeutics to Participate in Upcoming Investor Conferences

RAPP Latest SEC Filings

Jul 10, 2025
[EFFECT] Rapport Therapeutics, Inc. SEC Filing
Jul 1, 2025
[S-3] Rapport Therapeutics, Inc. Shelf Registration Statement
Jul 1, 2025
[S-3] Rapport Therapeutics, Inc. Shelf Registration Statement
Jun 18, 2025
[Form 4] Rapport Therapeutics, Inc. Insider Trading Activity
Jun 18, 2025
[Form 4] Rapport Therapeutics, Inc. Insider Trading Activity

RAPP Stock Data

439.43M
34.20M
6.59%
100.74%
4.94%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON